Dendritic cell vaccine therapy of cutaneous melanoma after the radical surgery

N. N. Petenko; Петенко Н. Н.; I. N. Mikhailova; Михайлова И. Н.; G. Z. Chkadua; Чкадуа Г. З.; L. V. Demidov; Демидов Л. В.; A. U. Barishnikov; Барышников А. Ю.

Dendritic cell vaccine therapy of cutaneous melanoma after the radical surgery

Authors: Petenko N.N.¹, Mikhailova I.N.¹, Chkadua G.Z.¹, Demidov L.V.¹, Barishnikov A.U.¹
Affiliations:
1. N.N. Blokhin Russian Cancer Research Center
Issue: Vol 7, No 1 (2015)
Pages: 43-49
Section: TUMORS OF THE SKIN
Published: 23.01.2015
URL: https://sarbon.abvpress.ru/jour/article/view/437
ID: 437

Cite item

Full Text

Abstract
About the authors
References
Supplementary files
Statistics

Abstract

Dendritic cell vaccine therapy induces activation of antitumor immune response, which in some cases can cause tumor regression even in advanced melanoma patients. Vaccine therapy after surgical treatment for prevention of tumor recurrence may be more effective. In this trial we present results for clinical and immunological effectiveness of dendritic vaccine therapy of stage III–IV cutaneous melanoma after surgical treatment.